Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus‐based high‐throughput screening
Authors:
Open Access
- 18 January 2024
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (1) , e29382
Abstract
Japanese encephalitis (JE) caused by JE virus (JEV), remains a global public health concern. Currently, there is no specific antiviral drug approved for the treatment of JE. While vaccines are available for prevention, they may not cover all at‐risk populations. This underscores the urgent need for prophylaxis and potent anti‐JEV drugs. In this context, a high‐content JEV reporter system expressing Nanoluciferase (Nluc) was developed and utilized for a high‐throughput screening (HTS) of a commercial antiviral library to identify potential JEV drug candidates. Remarkably, this screening process led to the discovery of five drugs with outstanding antiviral activity. Further mechanism of action analysis revealed that cepharanthine, an old clinically approved drug, directly inhibited virus replication by blocking GTP binding to the JEV RNA‐dependent RNA polymerase. Additionally, treatment with cepharanthine in mice models alleviated JEV infection. These findings warrant further investigation into the potential anti‐JEV activity of cepharanthine as a new therapeutic approach for the treatment of JEV infection. The HTS method employed here proves to be an accurate and convenient approach that facilitates the rapid development of antiviral drugs.Keywords
This publication has 51 references indexed in Scilit:
- Role of Intracellular Ca2+and Na+/Ca2+Exchanger in the Pathogenesis of Contrast-Induced Acute Kidney InjuryBioMed Research International, 2013
- Estimated global incidence of Japanese encephalitis:Bulletin of the World Health Organization, 2011
- Flavivirus Cell Entry and Membrane FusionViruses, 2011
- An adenosine nucleoside inhibitor of dengue virusProceedings of the National Academy of Sciences, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Pathogenesis of Flavivirus Infections: Using and Abusing the Host CellCell Host & Microbe, 2009
- Past, Present, and Future of Japanese EncephalitisEmerging Infectious Diseases, 2009
- Production of Pseudoinfectious Yellow Fever Virus with a Two-Component GenomeJournal of Virology, 2007
- Potent Inhibition of HIV Type 1 Replication by an Antiinflammatory Alkaloid, Cepharanthine, in Chronically Infected Monocytic CellsAIDS Research and Human Retroviruses, 1998